908 Devices And Terumo Blood And Cell Technologies Collaborate To Add On-Line Analytics To Quantum Flex Cell Expansion System
Portfolio Pulse from Benzinga Newsdesk
908 Devices and Terumo Blood and Cell Technologies are collaborating to add on-line analytics to the Quantum Flex Cell Expansion System. The aim is to increase manufacturing efficiencies and patient accessibility and safety in cell therapy.
November 06, 2023 | 10:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
908 Devices' partnership with Terumo Blood and Cell Technologies to enhance the Quantum Flex Cell Expansion System could potentially boost the company's market position and revenues.
The partnership with Terumo Blood and Cell Technologies to enhance a key product, the Quantum Flex Cell Expansion System, could potentially increase 908 Devices' market share and revenues. This is likely to have a positive impact on the company's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100